4.0 Article

Deep brain stimulation in Parkinson's disease: analysis of brain fractional anisotropy differences in operated patients

Journal

REVISTA DE NEUROLOGIA
Volume 74, Issue 4, Pages 125-133

Publisher

REVISTA DE NEUROLOGIA
DOI: 10.33588/rn.7404.2021196

Keywords

Connectivity; Deep brain stimulation; Movement disorder's surgery; Neuronal networks; Parkinson's disease; Tractography

Funding

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  2. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  3. National Institute on Aging
  4. National Institute of Biomedical Imaging and Bioengineering
  5. AbbVie
  6. Alzheimer's Drug Discovery Foundation
  7. Araclon Biotech
  8. BioClinica, Inc.
  9. Biogen
  10. Bristol-Myers Squibb Company
  11. CereSpir, Inc.
  12. Cogstate
  13. Eisai Inc.
  14. Elan Pharmaceuticals, Inc.
  15. Eli Lilly and Company
  16. EuroImmun
  17. Genentech, Inc.
  18. Fujirebio
  19. GE Healthcare
  20. IXICO Ltd.
  21. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  22. Johnson & Johnson Pharmaceutical Research & Development LLC.
  23. Lumosity
  24. Lundbeck
  25. Merck Co., Inc.
  26. Meso Scale Diagnostics, LLC.
  27. NeuroRx Research
  28. Neurotrack Technologies
  29. Novartis Pharmaceuticals Corporation
  30. Pfizer Inc.
  31. Piramal Imaging
  32. Servier
  33. Takeda Pharmaceutical Company
  34. Transition Therapeutics
  35. Canadian Institutes of Health Research
  36. F. Hoffmann-La Roche Ltd
  37. Alzheimer's Association

Ask authors/readers for more resources

This study evaluated the global changes in the connectivity of the large-scale structural network in Parkinson's disease patients who received subthalamic DBS. The results showed significantly higher fractional anisotropy in widespread areas of the cerebral white matter in PD patients treated with bilateral subthalamic DBS, suggesting that neuromodulation produces connectivity changes in different neural networks.
Introduction. Deep brain stimulation (DBS) of the subthalamic nucleus is currently an evidence-based therapeutic option for motor symptoms in patients with Parkinson's disease (PD), although other non-motor symptoms can be affected by stimulation. Aim. Our objective is to evaluate the global changes in the connectivity of the large-scale structural network in PD patients that have obtained a benefit from subthalamic DBS. Subjects and methods. Retrospective study of 31 subjects: 7 PD patients with subthalamic DBS (group A), 12 age and gender-matched non-operated PD (B) and 12 healthy controls (C). All subjects had undergone a 1.5 T brain MRI with DTI. DICOM images were processed with the FSL5.0 software and TBSS tool. Results. The study group comprised 23 men and 8 women. No statistically significant differences in age, gender, scores on the H&Y scale and mean follow-up between group A and B were found, and in age and gender between groups A and C. Statistical analysis revealed differences in the fractional anisotropy of the different groups in certain areas: bilateral corticospinal tract, anterior thalamic radiations, bilateral fronto-occipital fascicle, both superior longitudinal fascicles, and left inferior longitudinal fascicle. Conclusions. In our series, PD patients treated with bilateral subthalamic DBS showed a significantly higher fractional anisotropy in widespread areas of the cerebral white matter; suggesting that neuromodulation produces connectivity changes in different neural networks.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available